Silence Therapeutics Ownership | Who Owns Silence Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Silence Therapeutics Ownership Summary

Silence Therapeutics is owned by 15.39% institutional investors, 13.73% insiders, and 70.87% retail investors. Artal group is the largest institutional shareholder, holding 6.32% of SLN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 1.36% of its assets in Silence Therapeutics shares.

SLN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Silence Therapeutics	15.39%	13.73%	70.87%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Artal group	2.78M	6.32%	$52.81M
Lombard odier asset management (usa)	2.41M	5.47%	$36.76M
Frazier life sciences management	1.15M	2.61%	$21.82M
Tcg crossover management	3.03M	2.16%	$20.87M
Siren	2.83M	2.02%	$19.48M
Redmile group	2.40M	1.71%	$16.51M
Vivo capital	1.11M	0.79%	$7.61M
Sg americas securities	343.20K	0.78%	$6.52M
Nantahala capital management	1.05M	0.75%	$7.22M
Morgan stanley	303.99K	0.69%	$5.78M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aquilo capital management	367.21K	3.81%	$2.53M
Lombard odier asset management (usa)	2.41M	2.72%	$36.76M
Tcg crossover management	3.03M	2.04%	$20.87M
Artal group	2.78M	1.35%	$52.81M
M28 capital management lp	185.10K	1.25%	$1.27M
Redmile group	2.40M	1.15%	$16.51M
Saturn v capital management	395.02K	1.06%	$2.72M
Nextech invest	952.40K	1.06%	$6.55M
Frazier life sciences management	1.15M	1.02%	$21.82M
Siren	2.83M	0.86%	$19.48M

Top Buyers

Holder	Shares	% Assets	Change
Nantahala capital management	1.05M	0.31%	849.68K
Redmile group	2.40M	1.15%	500.00K
Sg americas securities	343.20K	0.04%	336.20K
Marshall wace, llp	488.89K	0.00%	320.47K
Ubs group	356.07K	0.00%	285.41K

Top Sellers

Holder	Shares	% Assets	Change
Lombard odier asset management (europe)	-	-	-2.24M
Janus henderson group	-	-	-1.09M
Deep track capital, lp	-	-	-1.00M
Polar capital	-	-	-1.00M
Millennium management	473.55K	0.00%	-636.68K

New Positions

Holder	Shares	% Assets	Change	Value
Blackrock funding, inc. /de	211.51K	-	211.51K	$1.46M
Acadian asset management	19.47K	0.00%	19.47K	$133.00K
Commonwealth of pennsylvania public school empls retrmt sys	19.47K	0.00%	19.47K	$133.93K
Fny investment advisers	17.52K	0.06%	17.52K	$120.00K
Ameriprise financial	16.36K	-	16.36K	$112.56K

Sold Out

Holder	Change
Lazard asset management	-60.00
Values first advisors	-3.09K
Advisors preferred	-5.32K
Quarry lp	-6.00K
Vestcor	-8.80K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	61	-14.08%	21,582,466	-23.46%	15	0.42%	35	-5.41%	12	-20.00%
Sep 30, 2024	70	-	28,105,051	3.61%	60	1.79%	37	12.12%	14	-26.32%
Jun 30, 2024	69	9.52%	27,125,546	-1.84%	61	1.11%	33	-31.25%	18	63.64%
Mar 31, 2024	63	85.29%	27,634,707	34.54%	74	2.46%	48	182.35%	11	83.33%
Dec 31, 2023	34	21.43%	20,540,070	4.15%	55	1.85%	17	112.50%	6	-14.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Eventide Healthcare & Life Sciences I	640.00K	1.36%	-
International Biotechnology Ord	601.48K	1.27%	132.51K
Polar Capital Biotech S Inc	467.15K	0.99%	-532.85K
MEDICAL BioHealth EUR Acc	295.00K	0.62%	72.00K
iShares Biotechnology ETF	158.67K	0.34%	-17.95K
T. Rowe Price Health Sciences	95.65K	0.20%	95.65K
BIT Biotech Opportunities S	92.43K	0.20%	-14.87K
Tema Obesity & Cardiometabolic ETF	76.77K	0.16%	-
Galileo - Biotech Innovation Fund S USD	58.65K	0.12%	-
Aesculape SRI IC	47.00K	0.10%	47.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 31, 2025	Griffiths Richard Ian	-	Buy	$283.00K
Mar 28, 2025	Griffiths Richard Ian	-	Buy	$179.00K
Mar 31, 2025	Griffiths Richard Ian	-	Buy	$346.00K
Mar 27, 2025	Griffiths Richard Ian	-	Buy	$166.00K
Mar 05, 2025	Griffiths Richard Ian	-	Buy	$101.84K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	13	-

SLN Ownership FAQ

Who Owns Silence Therapeutics?

Silence Therapeutics shareholders are primarily institutional investors at 15.39%, followed by 13.73% insiders and 70.88% retail investors. The average institutional ownership in Silence Therapeutics's industry, Biotech Stocks , is 68.48%, which Silence Therapeutics falls below.

Who owns the most shares of Silence Therapeutics?

Silence Therapeutics’s largest shareholders are Artal group (2.78M shares, 6.32%), Lombard odier asset management (usa) (2.41M shares, 5.47%), and Frazier life sciences management (1.15M shares, 2.61%). Together, they hold 14.41% of Silence Therapeutics’s total shares outstanding.

Does Blackrock own Silence Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Silence Therapeutics.

Who is Silence Therapeutics’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Silence Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.81% of its assets in 367.21K Silence Therapeutics shares, valued at 2.53M$.

Who is the top mutual fund holder of Silence Therapeutics shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Silence Therapeutics shares, with 1.36% of its total shares outstanding invested in 640K Silence Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools